The Journal of clinical psychiatry
-
Randomized Controlled Trial Clinical Trial
Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: an open-label trial.
To evaluate the efficacy and safety of mirtazapine in depressed outpatients who have shown nonresponse or intolerance to selective serotonin reuptake inhibitor (SSRI) therapy. ⋯ These results suggest that an immediate switch to mirtazapine may be a valid therapeutic option among patients who cannot tolerate or do not respond to SSRIs.
-
Letter Clinical Trial
Gabapentin for the treatment of patients with somatization disorder.